AHA GUIDELINES Bundle (free trial)

Atrial Fibrillation 2023 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387790

Contents of this Issue

Navigation

Page 114 of 131

115 10.6. Wolff-Parkinson-White (WPW) and Pre-Excitation Syndromes COR LOE Recommendations 1 B-NR 1. Patients with AF with rapid anterograde conduction (pre- excited AF), and hemodynamic instability should be treated with electrical cardioversion. 1 B-NR 2. For patients with AF with rapid anterograde conduction (pre-excited AF), catheter ablation of accessory pathways (APs) is recommended. 1 C-LD 3. In patients with AF with rapid anterograde conduction (pre- excited AF) and hemodynamic stability, pharmacological cardioversion with intravenous ibutilide or intravenous procainamide is recommended as an alternative to elective cardioversion. 3: Harm B-NR 4. For patients with AF with anterograde accessory pathway conduction (pre-excited AF), pharmacological agents that block AV nodal conduction (verapamil, diltiazem, amiodarone, digoxin, adenosine, or beta blockers) are contraindicated due to risk of precipitating VF or hemodynamic deterioration. 10.5. AF and VHD

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Atrial Fibrillation 2023 Update